Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Acinetobacter Infections Treatment will have significant change from previous year. By the most conservative estimates of global Acinetobacter Infections Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Acinetobacter Infections Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Acinetobacter Infections Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Segmentation by pipeline: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small Molecule Antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acinetobacter Infections Treatment Market Size 2016-2026
2.1.2 Acinetobacter Infections Treatment Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Acinetobacter Infections Treatment Segment by Type
2.2.1 Sulbactam
2.2.2 Sulbactam
2.2.3 Aminoglycosides
2.2.4 Polymyxins
2.2.5 Tetracyclines
2.2.6 Others
2.3 Acinetobacter Infections Treatment Market Size by Type
2.3.1 Global Acinetobacter Infections Treatment Market Size CAGR by Type
2.3.2 Global Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
2.4 Acinetobacter Infections Treatment Segment by Pipeline
2.4.1 ETX2514
2.4.2 Nacubactam RG6080
2.4.3 Arenicin
2.4.4 VXD-001
2.4.5 Small Molecule Antibiotic
2.4.6 AR-401 mAB
2.4.7 LCB01-0371 (PO)
2.4.8 GN-4474
2.4.9 Antibacterial Antibody
2.4.10 Others
2.5 Acinetobacter Infections Treatment Market Size by Pipeline
2.5.1 Global Acinetobacter Infections Treatment Market Size CAGR by Pipeline
2.5.2 Global Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
3 Acinetobacter Infections Treatment Market Size by Players
3.1 Acinetobacter Infections Treatment Market Size Market Share by Players
3.1.1 Global Acinetobacter Infections Treatment Revenue by Players (2019-2021E)
3.1.2 Global Acinetobacter Infections Treatment Revenue Market Share by Players (2019-2021E)
3.2 Global Acinetobacter Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Acinetobacter Infections Treatment by Regions
4.1 Acinetobacter Infections Treatment Market Size by Regions (2016-2021)
4.2 Americas Acinetobacter Infections Treatment Market Size Growth (2016-2021)
4.3 APAC Acinetobacter Infections Treatment Market Size Growth (2016-2021)
4.4 Europe Acinetobacter Infections Treatment Market Size Growth (2016-2021)
4.5 Middle East & Africa Acinetobacter Infections Treatment Market Size Growth (2016-2021)
5 Americas
5.1 Americas Acinetobacter Infections Treatment Market Size by Country (2016-2021)
5.2 Americas Acinetobacter Infections Treatment Market Size by Type (2016-2021)
5.3 Americas Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acinetobacter Infections Treatment Market Size by Region (2016-2021)
6.2 APAC Acinetobacter Infections Treatment Market Size by Type (2016-2021)
6.3 APAC Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Acinetobacter Infections Treatment by Country (2016-2021)
7.2 Europe Acinetobacter Infections Treatment Market Size by Type (2016-2021)
7.3 Europe Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acinetobacter Infections Treatment by Region (2016-2021)
8.2 Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2016-2021)
8.3 Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Acinetobacter Infections Treatment Market Forecast
10.1 Global Acinetobacter Infections Treatment Forecast by Regions (2021-2026)
10.1.1 Global Acinetobacter Infections Treatment Forecast by Regions (2021-2026)
10.1.2 Americas Acinetobacter Infections Treatment Forecast
10.1.3 APAC Acinetobacter Infections Treatment Forecast
10.1.4 Europe Acinetobacter Infections Treatment Forecast
10.1.5 Middle East & Africa Acinetobacter Infections Treatment Forecast
10.2 Americas Acinetobacter Infections Treatment Forecast by Countries (2021-2026)
10.2.1 United States Acinetobacter Infections Treatment Market Forecast
10.2.2 Canada Acinetobacter Infections Treatment Market Forecast
10.2.3 Mexico Acinetobacter Infections Treatment Market Forecast
10.2.4 Brazil Acinetobacter Infections Treatment Market Forecast
10.3 APAC Acinetobacter Infections Treatment Forecast by Region (2021-2026)
10.3.1 China Acinetobacter Infections Treatment Market Forecast
10.3.2 Japan Acinetobacter Infections Treatment Market Forecast
10.3.3 Korea Acinetobacter Infections Treatment Market Forecast
10.3.4 Southeast Asia Acinetobacter Infections Treatment Market Forecast
10.3.5 India Acinetobacter Infections Treatment Market Forecast
10.3.6 Australia Acinetobacter Infections Treatment Market Forecast
10.4 Europe Acinetobacter Infections Treatment Forecast by Country (2021-2026)
10.4.1 Germany Acinetobacter Infections Treatment Market Forecast
10.4.2 France Acinetobacter Infections Treatment Market Forecast
10.4.3 UK Acinetobacter Infections Treatment Market Forecast
10.4.4 Italy Acinetobacter Infections Treatment Market Forecast
10.4.5 Russia Acinetobacter Infections Treatment Market Forecast
10.5 Middle East & Africa Acinetobacter Infections Treatment Forecast by Region (2021-2026)
10.5.1 Egypt Acinetobacter Infections Treatment Market Forecast
10.5.2 South Africa Acinetobacter Infections Treatment Market Forecast
10.5.3 Israel Acinetobacter Infections Treatment Market Forecast
10.5.4 Turkey Acinetobacter Infections Treatment Market Forecast
10.5.5 GCC Countries Acinetobacter Infections Treatment Market Forecast
10.6 Global Acinetobacter Infections Treatment Forecast by Type (2021-2026)
10.7 Global Acinetobacter Infections Treatment Forecast by Pipeline (2021-2026)
11 Key Players Analysis
11.1 Entasis Therapeutics
11.1.1 Entasis Therapeutics Company Information
11.1.2 Entasis Therapeutics Acinetobacter Infections Treatment Product Offered
11.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Entasis Therapeutics Main Business Overview
11.1.5 Entasis Therapeutics Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Acinetobacter Infections Treatment Product Offered
11.2.3 Roche Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Adenium Biotech
11.3.1 Adenium Biotech Company Information
11.3.2 Adenium Biotech Acinetobacter Infections Treatment Product Offered
11.3.3 Adenium Biotech Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Adenium Biotech Main Business Overview
11.3.5 Adenium Biotech Latest Developments
11.4 Vaxdyn
11.4.1 Vaxdyn Company Information
11.4.2 Vaxdyn Acinetobacter Infections Treatment Product Offered
11.4.3 Vaxdyn Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Vaxdyn Main Business Overview
11.4.5 Vaxdyn Latest Developments
11.5 Hsiri Therapeutics
11.5.1 Hsiri Therapeutics Company Information
11.5.2 Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered
11.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Hsiri Therapeutics Main Business Overview
11.5.5 Hsiri Therapeutics Latest Developments
11.6 Aridis Pharmaceuticals
11.6.1 Aridis Pharmaceuticals Company Information
11.6.2 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Aridis Pharmaceuticals Main Business Overview
11.6.5 Aridis Pharmaceuticals Latest Developments
11.7 LegoChem Biosciences
11.7.1 LegoChem Biosciences Company Information
11.7.2 LegoChem Biosciences Acinetobacter Infections Treatment Product Offered
11.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 LegoChem Biosciences Main Business Overview
11.7.5 LegoChem Biosciences Latest Developments
11.8 Atterx Biotherapeutics
11.8.1 Atterx Biotherapeutics Company Information
11.8.2 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered
11.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Atterx Biotherapeutics Main Business Overview
11.8.5 Atterx Biotherapeutics Latest Developments
11.9 Achaogen
11.9.1 Achaogen Company Information
11.9.2 Achaogen Acinetobacter Infections Treatment Product Offered
11.9.3 Achaogen Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Achaogen Main Business Overview
11.9.5 Achaogen Latest Developments
11.10 Peptilogics
11.10.1 Peptilogics Company Information
11.10.2 Peptilogics Acinetobacter Infections Treatment Product Offered
11.10.3 Peptilogics Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Peptilogics Main Business Overview
11.10.5 Peptilogics Latest Developments
11. Sealife PHARMA
11.11.1 Sealife PHARMA Company Information
11.11.2 Sealife PHARMA Acinetobacter Infections Treatment Product Offered
11.11.3 Sealife PHARMA Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Sealife PHARMA Main Business Overview
11.11.5 Sealife PHARMA Latest Developments
11.12 Shionogi
11.12.1 Shionogi Company Information
11.12.2 Shionogi Acinetobacter Infections Treatment Product Offered
11.12.3 Shionogi Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Shionogi Main Business Overview
11.12.5 Shionogi Latest Developments
11.13 Techulon
11.13.1 Techulon Company Information
11.13.2 Techulon Acinetobacter Infections Treatment Product Offered
11.13.3 Techulon Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Techulon Main Business Overview
11.13.5 Techulon Latest Developments
11.14 Tetraphase Pharmaceuticals
11.14.1 Tetraphase Pharmaceuticals Company Information
11.14.2 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered
11.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Tetraphase Pharmaceuticals Main Business Overview
11.14.5 Tetraphase Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Acinetobacter Infections Treatment Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Sulbactam
Table 3. Major Players of Carbapenems
Table 4. Major Players of Aminoglycosides
Table 5. Major Players of Polymyxins
Table 6. Major Players of Tetracyclines
Table 7. Major Players of Others
Table 8. Acinetobacter Infections Treatment Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 9. Global Acinetobacter Infections Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 10. Global Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
Table 11. Acinetobacter Infections Treatment Market Size CAGR by Pipeline (2016-2021) & ($ Millions)
Table 12. Global Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) & ($ Millions)
Table 13. Global Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
Table 14. Global Acinetobacter Infections Treatment Revenue by Players (2019-2021E) & ($ Millions)
Table 15. Global Acinetobacter Infections Treatment Revenue Market Share by Players (2019-2021E)
Table 16. Acinetobacter Infections Treatment Key Players Head office and Products Offered
Table 17. Acinetobacter Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Acinetobacter Infections Treatment Market Size by Regions 2016-2021 & ($ Millions)
Table 21. Global Acinetobacter Infections Treatment Market Size Market Share by Regions 2016-2021
Table 22. Americas Acinetobacter Infections Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 23. Americas Acinetobacter Infections Treatment Market Size Market Share by Country (2016-2021)
Table 24. Americas Acinetobacter Infections Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 25. Americas Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
Table 26. Americas Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) & ($ Millions)
Table 27. Americas Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
Table 28. APAC Acinetobacter Infections Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 29. APAC Acinetobacter Infections Treatment Market Size Market Share by Region (2016-2021)
Table 30. APAC Acinetobacter Infections Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 31. APAC Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
Table 32. APAC Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) & ($ Millions)
Table 33. APAC Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
Table 34. Europe Acinetobacter Infections Treatment Market Size by Country (2016-2021) & ($ Millions)
Table 35. Europe Acinetobacter Infections Treatment Market Size Market Share by Country (2016-2021)
Table 36. Europe Acinetobacter Infections Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 37. Europe Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
Table 38. Europe Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) & ($ Millions)
Table 39. Europe Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
Table 40. Middle East & Africa Acinetobacter Infections Treatment Market Size by Region (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Region (2016-2021)
Table 42. Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Type (2016-2021)
Table 44. Middle East & Africa Acinetobacter Infections Treatment Market Size by Pipeline (2016-2021) & ($ Millions)
Table 45. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Pipeline (2016-2021)
Table 46. Key and Potential Regions of Acinetobacter Infections Treatment
Table 47. Key Application and Potential Industries of Acinetobacter Infections Treatment
Table 48. Key Challenges of Acinetobacter Infections Treatment
Table 49. Key Trends of Acinetobacter Infections Treatment
Table 50. Global Acinetobacter Infections Treatment Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 51. Global Acinetobacter Infections Treatment Market Size Market Share Forecast by Regions (2021-2026)
Table 52. Global Acinetobacter Infections Treatment Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 53. Global Acinetobacter Infections Treatment Market Size Market Share Forecast by Type (2021-2026)
Table 54. Global Acinetobacter Infections Treatment Market Size Forecast by Pipeline (2021-2026) & ($ Millions)
Table 55. Global Acinetobacter Infections Treatment Market Size Market Share Forecast by Pipeline (2021-2026)
Table 56. Entasis Therapeutics Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 57. Entasis Therapeutics Acinetobacter Infections Treatment Product Offered
Table 58. Entasis Therapeutics Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 59. Entasis Therapeutics Main Business
Table 60. Entasis Therapeutics Latest Developments
Table 61. Roche Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 62. Roche Acinetobacter Infections Treatment Product Offered
Table 63. Roche Main Business
Table 64. Roche Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 65. Roche Latest Developments
Table 66. Adenium Biotech Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 67. Adenium Biotech Acinetobacter Infections Treatment Product Offered
Table 68. Adenium Biotech Main Business
Table 69. Adenium Biotech Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 70. Adenium Biotech Latest Developments
Table 71. Vaxdyn Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 72. Vaxdyn Acinetobacter Infections Treatment Product Offered
Table 73. Vaxdyn Main Business
Table 74. Vaxdyn Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 75. Vaxdyn Latest Developments
Table 76. Hsiri Therapeutics Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 77. Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered
Table 78. Hsiri Therapeutics Main Business
Table 79. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 80. Hsiri Therapeutics Latest Developments
Table 81. Aridis Pharmaceuticals Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 82. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered
Table 83. Aridis Pharmaceuticals Main Business
Table 84. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 85. Aridis Pharmaceuticals Latest Developments
Table 86. LegoChem Biosciences Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 87. LegoChem Biosciences Acinetobacter Infections Treatment Product Offered
Table 88. LegoChem Biosciences Main Business
Table 89. LegoChem Biosciences Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 90. LegoChem Biosciences Latest Developments
Table 91. Atterx Biotherapeutics Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 92. Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered
Table 93. Atterx Biotherapeutics Main Business
Table 94. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 95. Atterx Biotherapeutics Latest Developments
Table 96. Achaogen Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 97. Achaogen Acinetobacter Infections Treatment Product Offered
Table 98. Achaogen Main Business
Table 99. Achaogen Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 100. Achaogen Latest Developments
Table 101. Peptilogics Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 102. Peptilogics Acinetobacter Infections Treatment Product Offered
Table 103. Peptilogics Main Business
Table 104. Peptilogics Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 105. Peptilogics Latest Developments
Table 106. Sealife PHARMA Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 107. Sealife PHARMA Acinetobacter Infections Treatment Product Offered
Table 108. Sealife PHARMA Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 109. Sealife PHARMA Main Business
Table 110. Sealife PHARMA Latest Developments
Table 111. Shionogi Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 112. Shionogi Acinetobacter Infections Treatment Product Offered
Table 113. Shionogi Main Business
Table 114. Shionogi Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 115. Shionogi Latest Developments
Table 116. Techulon Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 117. Techulon Acinetobacter Infections Treatment Product Offered
Table 118. Techulon Main Business
Table 119. Techulon Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 120. Techulon Latest Developments
Table 121. Tetraphase Pharmaceuticals Details, Company Type, Acinetobacter Infections Treatment Area Served and Its Competitors
Table 122. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered
Table 123. Tetraphase Pharmaceuticals Main Business
Table 124. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 125. Tetraphase Pharmaceuticals Latest Developments
List of Figures
Figure 1. Acinetobacter Infections Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acinetobacter Infections Treatment Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Acinetobacter Infections Treatment Market Size Market Share by Type in 2020
Figure 7. Acinetobacter Infections Treatment in ETX2514
Figure 8. Global Acinetobacter Infections Treatment Market: ETX2514 (2016-2021) & ($ Millions)
Figure 9. Acinetobacter Infections Treatment in Nacubactam RG6080
Figure 10. Global Acinetobacter Infections Treatment Market: Nacubactam RG6080 (2016-2021) & ($ Millions)
Figure 11. Acinetobacter Infections Treatment in Arenicin
Figure 12. Global Acinetobacter Infections Treatment Market: Arenicin (2016-2021) & ($ Millions)
Figure 13. Acinetobacter Infections Treatment in VXD-001
Figure 14. Global Acinetobacter Infections Treatment Market: VXD-001 (2016-2021) & ($ Millions)
Figure 15. Acinetobacter Infections Treatment in Small Molecule Antibiotic
Figure 16. Global Acinetobacter Infections Treatment Market: Small Molecule Antibiotic (2016-2021) & ($ Millions)
Figure 17. Acinetobacter Infections Treatment in AR-401 mAB
Figure 18. Global Acinetobacter Infections Treatment Market: AR-401 mAB (2016-2021) & ($ Millions)
Figure 19. Acinetobacter Infections Treatment in LCB01-0371 (PO)
Figure 20. Global Acinetobacter Infections Treatment Market: LCB01-0371 (PO) (2016-2021) & ($ Millions)
Figure 21. Acinetobacter Infections Treatment in GN-4474
Figure 22. Global Acinetobacter Infections Treatment Market: GN-4474 (2016-2021) & ($ Millions)
Figure 23. Acinetobacter Infections Treatment in Antibacterial Antibody
Figure 24. Global Acinetobacter Infections Treatment Market: Antibacterial Antibody (2016-2021) & ($ Millions)
Figure 25. Acinetobacter Infections Treatment in Others
Figure 26. Global Acinetobacter Infections Treatment Market: Others (2016-2021) & ($ Millions)
Figure 27. Global Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2020
Figure 28. Global Acinetobacter Infections Treatment Revenue Market Share by Player in 2020
Figure 29. Global Acinetobacter Infections Treatment Market Size Market Share by Regions (2016-2021)
Figure 30. Americas Acinetobacter Infections Treatment Market Size 2016-2021 ($ Millions)
Figure 31. APAC Acinetobacter Infections Treatment Market Size 2016-2021 ($ Millions)
Figure 32. Europe Acinetobacter Infections Treatment Market Size 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Acinetobacter Infections Treatment Market Size 2016-2021 ($ Millions)
Figure 34. Americas Acinetobacter Infections Treatment Market Size Market Share by Country in 2020
Figure 35. Americas Acinetobacter Infections Treatment Market Size Market Share by Type in 2020
Figure 36. Americas Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2020
Figure 37. United States Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 38. Canada Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 39. Mexico Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 40. APAC Acinetobacter Infections Treatment Market Size Market Share by Regions in 2020
Figure 41. APAC Acinetobacter Infections Treatment Market Size Market Share by Type in 2020
Figure 42. APAC Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2020
Figure 43. China Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 44. Japan Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 45. Korea Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 47. India Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 48. Australia Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 49. Europe Acinetobacter Infections Treatment Market Size Market Share by Country in 2020
Figure 50. Europe Acinetobacter Infections Treatment Market Size Market Share by Type in 2020
Figure 51. Europe Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2020
Figure 52. Germany Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 53. France Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 54. UK Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 55. Italy Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 56. Russia Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 57. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Region in 2020
Figure 58. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Type in 2020
Figure 59. Middle East & Africa Acinetobacter Infections Treatment Market Size Market Share by Pipeline in 2020
Figure 60. Egypt Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 61. South Africa Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 62. Israel Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 63. Turkey Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 64. GCC Country Acinetobacter Infections Treatment Market Size Growth 2016-2021 ($ Millions)
Figure 65. Americas Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 66. APAC Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 67. Europe Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 68. Middle East & Africa Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 69. United States Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 70. Canada Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 71. Mexico Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 72. Brazil Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 73. China Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 74. Japan Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 75. Korea Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 76. Southeast Asia Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 77. India Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 78. Australia Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 79. Germany Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 80. France Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 81. UK Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 82. Italy Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 83. Russia Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 84. Spain Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 85. Egypt Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 86. South Africa Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 87. Israel Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 88. Turkey Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
Figure 89. GCC Country Acinetobacter Infections Treatment Market Size 2021-2026 ($ Millions)
